515 related articles for article (PubMed ID: 32808238)
1. Antibodies from Multiple Sclerosis Brain Identified Epstein-Barr Virus Nuclear Antigen 1 & 2 Epitopes which Are Recognized by Oligoclonal Bands.
Wang Z; Kennedy PG; Dupree C; Wang M; Lee C; Pointon T; Langford TD; Graner MW; Yu X
J Neuroimmune Pharmacol; 2021 Sep; 16(3):567-580. PubMed ID: 32808238
[TBL] [Abstract][Full Text] [Related]
2. No evidence for intrathecal IgG synthesis to Epstein Barr virus nuclear antigen-1 in multiple sclerosis.
Jafari N; van Nierop GP; Verjans GM; Osterhaus AD; Middeldorp JM; Hintzen RQ
J Clin Virol; 2010 Sep; 49(1):26-31. PubMed ID: 20638898
[TBL] [Abstract][Full Text] [Related]
3. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
[TBL] [Abstract][Full Text] [Related]
4. Oligoclonal IgG antibodies in multiple sclerosis target patient-specific peptides.
Graner M; Pointon T; Manton S; Green M; Dennison K; Davis M; Braiotta G; Craft J; Edwards T; Polonsky B; Fringuello A; Vollmer T; Yu X
PLoS One; 2020; 15(2):e0228883. PubMed ID: 32084151
[TBL] [Abstract][Full Text] [Related]
5. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
[TBL] [Abstract][Full Text] [Related]
6. The elusive nature of the oligoclonal bands in multiple sclerosis.
Kennedy PGE; George W; Yu X
J Neurol; 2024 Jan; 271(1):116-124. PubMed ID: 37945762
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies.
Castellazzi M; Contini C; Tamborino C; Fasolo F; Roversi G; Seraceni S; Rizzo R; Baldi E; Tola MR; Bellini T; Granieri E; Fainardi E
J Neuroinflammation; 2014 Nov; 11():188. PubMed ID: 25391491
[TBL] [Abstract][Full Text] [Related]
8. Molecular approach to find target(s) for oligoclonal bands in multiple sclerosis.
Rand KH; Houck H; Denslow ND; Heilman KM
J Neurol Neurosurg Psychiatry; 1998 Jul; 65(1):48-55. PubMed ID: 9667560
[TBL] [Abstract][Full Text] [Related]
9. Recombinant antibodies derived from laser captured single plasma cells of multiple sclerosis brain identified phage peptides which may be used as tools for characterizing intrathecal IgG response.
Kennedy PGE; Graner MW; Walker D; Pointon T; Fringuello A; Yu X
J Neuroimmunol; 2020 Oct; 347():577319. PubMed ID: 32717427
[TBL] [Abstract][Full Text] [Related]
10. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Otto C; Hofmann J; Ruprecht K
Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus nuclear antigen-1 (EBNA-1) associated oligoclonal bands in patients with multiple sclerosis.
Rand KH; Houck H; Denslow ND; Heilman KM
J Neurol Sci; 2000 Feb; 173(1):32-9. PubMed ID: 10675577
[TBL] [Abstract][Full Text] [Related]
12. Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis.
Jons D; Persson Berg L; Sundström P; Haghighi S; Axelsson M; Thulin M; Bergström T; Andersen O
Mult Scler Relat Disord; 2021 Nov; 56():103288. PubMed ID: 34634626
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.
Franciotta D; Di Stefano AL; Jarius S; Zardini E; Tavazzi E; Ballerini C; Marchioni E; Bergamaschi R; Ceroni M
J Neuroimmunol; 2011 Jan; 230(1-2):160-3. PubMed ID: 21109310
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein.
Bray PF; Luka J; Bray PF; Culp KW; Schlight JP
Neurology; 1992 Sep; 42(9):1798-804. PubMed ID: 1381067
[TBL] [Abstract][Full Text] [Related]
15. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
[TBL] [Abstract][Full Text] [Related]
16. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA
J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129
[TBL] [Abstract][Full Text] [Related]
17. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
[TBL] [Abstract][Full Text] [Related]
18. Serologic Response to the Epstein-Barr Virus Peptidome and the Risk for Multiple Sclerosis.
Cortese M; Leng Y; Bjornevik K; Mitchell M; Healy BC; Mina MJ; Mancuso JD; Niebuhr DW; Munger KL; Elledge SJ; Ascherio A
JAMA Neurol; 2024 May; 81(5):515-524. PubMed ID: 38497939
[TBL] [Abstract][Full Text] [Related]
19. Virus-specific antibody indices may supplement the total IgG index in diagnostics of multiple sclerosis.
Kyllesbech C; Trier N; Slibinskas R; Ciplys E; Tsakiri A; Frederiksen JL; Houen G
J Neuroimmunol; 2022 Jun; 367():577868. PubMed ID: 35477126
[TBL] [Abstract][Full Text] [Related]
20. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM.
Lanz TV; Brewer RC; Ho PP; Moon JS; Jude KM; Fernandez D; Fernandes RA; Gomez AM; Nadj GS; Bartley CM; Schubert RD; Hawes IA; Vazquez SE; Iyer M; Zuchero JB; Teegen B; Dunn JE; Lock CB; Kipp LB; Cotham VC; Ueberheide BM; Aftab BT; Anderson MS; DeRisi JL; Wilson MR; Bashford-Rogers RJM; Platten M; Garcia KC; Steinman L; Robinson WH
Nature; 2022 Mar; 603(7900):321-327. PubMed ID: 35073561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
